Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Book value per share
Privia Health Group, Inc.'s book value per share at the end of fiscal 2025 was 6.5×, up 13.1% from 5.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 6.8×. Over the past ten years it has ranged from 0.0× (fiscal 2019) to 6.5× (fiscal 2025) — the current reading is the highest in ten years. Privia Health Group, Inc. ranks 14th of 44 Health Information Services companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 6.5× | 13.10% |
| FY2024 | 5.7× | 10.01% |
| FY2023 | 5.2× | 10.97% |
| FY2022 | 4.7× | 7.23% |
| FY2021 | 4.4× | 192.06% |
| FY2020 | 1.5× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 6.8× | 3.00% |
| Jun 2026 | 6.6× | 2.37% |
| Mar 2026 | 6.5× | 0.27% |
| Dec 2025 | 6.5× | 4.20% |
| 24 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| OMCL Omnicell, Inc. compare | 28.7× |
| WAY Waystar Holding Corp. compare | 21.0× |
| TDOC Teladoc Health, Inc. compare | 7.1× |
| PRVA Privia Health Group, Inc. | 6.8× |
| CERT Certara, Inc. compare | 6.4× |
| DOCS Doximity, Inc. compare | 5.2× |
| SDGR Schrodinger, Inc. compare | 4.0× |
| HTFL Heartflow, Inc. compare | 3.2× |
| GDRX GoodRx Holdings, Inc. compare | 1.9× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement